IGFBP7 expression in MM cells of newly diagnosed myeloma patients (n=62) is significantly decreased in patients with osteolytic lesions. Patients were grouped according to the absence (n = 16) or presence (n = 46) of osteolytic lesions at diagnosis. * P < 0.05 compared to control.